241 related articles for article (PubMed ID: 9617589)
1. The future use of complement inhibitors for the treatment of neurological diseases.
McGeer EG; McGeer PL
Drugs; 1998 Jun; 55(6):739-46. PubMed ID: 9617589
[TBL] [Abstract][Full Text] [Related]
2. Role of complement and perspectives for intervention in transplantation.
Chen G; Chen S; Chen X
Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
[TBL] [Abstract][Full Text] [Related]
3. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury.
Dong J; Pratt JR; Smith RA; Dodd I; Sacks SH
Mol Immunol; 1999; 36(13-14):957-63. PubMed ID: 10698350
[TBL] [Abstract][Full Text] [Related]
4. Targeting complement in therapy.
Kirschfink M
Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
[TBL] [Abstract][Full Text] [Related]
5. Controlling the complement system in inflammation.
Kirschfink M
Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
[TBL] [Abstract][Full Text] [Related]
6. Complement inhibitors in myocardial ischemia/reperfusion injury.
Lucchesi BR; Kilgore KS
Immunopharmacology; 1997 Dec; 38(1-2):27-42. PubMed ID: 9476112
[TBL] [Abstract][Full Text] [Related]
7. The complement system in myocardial ischaemia/reperfusion injury.
Kilgore KS; Friedrichs GS; Homeister JW; Lucchesi BR
Cardiovasc Res; 1994 Apr; 28(4):437-44. PubMed ID: 8181029
[No Abstract] [Full Text] [Related]
8. Therapeutic potential of complement inhibitors in myocardial ischaemia.
Lucchesi BR; Tanhehco EJ
Expert Opin Investig Drugs; 2000 May; 9(5):975-91. PubMed ID: 11060721
[TBL] [Abstract][Full Text] [Related]
9. Complement inhibitory therapeutics and xenotransplantation.
Ryan US
Nat Med; 1995 Sep; 1(9):967-8. PubMed ID: 7585227
[TBL] [Abstract][Full Text] [Related]
10. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of the complement system. Y2K update.
Asghar SS; Pasch MC
Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
[TBL] [Abstract][Full Text] [Related]
12. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
[No Abstract] [Full Text] [Related]
13. Complement activation and inhibition in myocardial ischemia and reperfusion injury.
Homeister JW; Lucchesi BR
Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849
[TBL] [Abstract][Full Text] [Related]
14. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
D'Ambrosio AL; Pinsky DJ; Connolly ES
Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the complement system currently in development for cardiovascular disease.
Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
[TBL] [Abstract][Full Text] [Related]
16. Role of complement in graft rejection after organ transplantation.
Bos IG; Ten Berge IJ; Hack CE
Transfus Med Rev; 2002 Jul; 16(3):251-64. PubMed ID: 12075562
[TBL] [Abstract][Full Text] [Related]
17. Ischaemia-reperfusion is an event triggered by immune complexes and complement.
Chan RK; Ibrahim SI; Verna N; Carroll M; Moore FD; Hechtman HB
Br J Surg; 2003 Dec; 90(12):1470-8. PubMed ID: 14648724
[TBL] [Abstract][Full Text] [Related]
18. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.
Barnum SR
Mol Med; 1999 Sep; 5(9):569-82. PubMed ID: 10551898
[No Abstract] [Full Text] [Related]
20. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement.
Monsinjon T; Richard V; Fontaine M
Fundam Clin Pharmacol; 2001 Oct; 15(5):293-306. PubMed ID: 11903498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
